The Patent Finder

Eutropics Pharmaceuticals, Inc.

11 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

1
Ending by 2030
Jul 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 23, 2026
    The maintenance fee for Method for predicting cancer sensitivity (US 11,656,230) comes due Nov 23, 2026. Unpaid by May 24, 2027, it lapses early.
  • 1 fee due Dec 9, 2026
    The maintenance fee for Compositions and methods useful for treating diseases (US 9,051,305) comes due Dec 9, 2026. Unpaid by Jun 9, 2027, it lapses early.
  • 1 fee due Mar 17, 2027
    The maintenance fee for Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivatives (US 10,413,549) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
  • 1 fee due Nov 5, 2027
    The maintenance fee for Methods for determining chemosensitivity and chemotoxicity (US 10,640,803) comes due Nov 5, 2027. Unpaid by May 5, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,168,755Antibodies specific to heterodimers of Bcl-2 family and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,987,2712,2'-Biphenazine Compounds and Methods Useful for Treating Disease
In force
 · High confidence
In forceHigh confidence
US 9,351,971Substituted 2,2′-biphenazines for treating diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,051,305Compositions and methods useful for treating diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,345,700Compositions and methods useful for treating diseases
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,360,473Assay system to identify therapeutic agents
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,413,549Methods and compositions useful for treating diseases involving Bcl-2 family proteins with isoquinoline and quinoline derivatives
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,640,803Methods for determining chemosensitivity and chemotoxicity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,656,230Method for predicting cancer sensitivity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,519,015Methods for determining chemosensitivity and chemotoxicity
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
Also on record, not counted in the 11: 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited